We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure

By HospiMedica International staff writers
Posted on 16 Mar 2026

Many patients experience anxiety and limited comprehension when preparing for invasive or device-assisted care. More...

Complex consent materials can leave people uncertain about risks, benefits, and what to expect on the day of treatment. To help address this challenge, clinicians tested a virtual reality experience to prepare patients for a noninvasive kidney stone procedure. Researchers now report that this approach improved understanding and reduced pre-procedural anxiety in people scheduled for treatment.

The project evaluated a virtual reality (VR) consent experience for shockwave lithotripsy at University Hospital Southampton. The research was presented on March 13, 2026, at the European Association of Urology (EAU) Congress 2026 in London. The initiative was developed with UK-based medical technology company Surgassists.

The VR module places the user in a virtual operating room and delivers a three-dimensional demonstration of shockwave lithotripsy, a noninvasive technique that uses high‑energy sound waves to fragment renal calculi. The animation zooms into the kidneys to show how shockwaves act on stones. Users can move around the room to view patient anatomy and surgical instruments from multiple angles, while on-screen prompts highlight key benefits and risks.

Investigators used questionnaires before and after the VR session to measure knowledge and anxiety. One hundred fifty adults aged 22 to 80 completed the experience as part of routine consent before planned lithotripsy. Participants reported better understanding of what to expect and lower anxiety after VR exposure. The effect was most pronounced in patients aged 65 years and older, and there was no difference by sex.

Because understanding, anxiety, and pain tolerance are linked, the team plans to explore whether VR‑based consenting could also affect pain outcomes. The work adds a structured, visual adjunct to standard information leaflets while keeping clinician discussion central to shared decision-making. Further evaluation will clarify durability of benefits and potential applications to other procedural pathways.

“There is currently a mismatch between the complexity of information provided to patients and the level which most people can comprehend. This risks people consenting to procedures they don't fully understand. VR has been shown to improve learning and knowledge retention, and our study suggests it could be used to help people to make more fully informed decisions about their health. We were also encouraged by what we saw in pain questionnaires, which gives us an important question to explore in future research,” said Solomon Bracey, a medical student at the University of Southampton, UK.

Related Links 
University Hospital Southampton
Surgassists


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.